Vor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors
Vor Biopharma Inc. (NASDAQ: VOR) has exploded back onto traders’ screens. On December 9, 2025, the small-cap biotech surged roughly 31%, closing around $10.95 versus $8.36 the prior session, on volume tens of millions of shares—far above its recent daily
